• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-N-氮杂糖GalNAc-异夫糖胺作为强效20家族β-N-乙酰己糖胺酶抑制剂的生化及结构评估

Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor.

作者信息

Mark B L, Vocadlo D J, Zhao D, Knapp S, Withers S G, James M N

机构信息

Department of Biochemistry, Canadian Institutes of Heath Research Group in Protein Structure and Function, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.

出版信息

J Biol Chem. 2001 Nov 9;276(45):42131-7. doi: 10.1074/jbc.M107154200. Epub 2001 Aug 24.

DOI:10.1074/jbc.M107154200
PMID:11522797
Abstract

Azasugar inhibitors of the isofagomine class are potent competitive inhibitors of configuration-retaining beta-glycosidases. This potency results from the formation of a strong electrostatic interaction between a protonated endocyclic nitrogen at the "anomeric" center of the inhibitor and the catalytic nucleophile of the enzyme. Although the majority of retaining beta-glycosidases use a mechanism involving a carboxylate residue as a nucleophile, Streptomyces plicatus beta-N-acetylhexos-aminidase (SpHEX) and related family 20 glycosidases lack such a catalytic residue and use instead the carbonyl oxygen of the 2-acetamido group of the substrate as a nucleophile to "attack" the anomeric center. Thus, a strong electrostatic interaction between the inhibitor and enzyme is not expected to occur; nonetheless, the 1-N-azasugar (2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidinium hydrochloride (GalNAc-isofagomine.HCl), which was synthesized and assayed for its ability to inhibit SpHEX, was found to be a potent competitive inhibitor of the enzyme (K(i) = 2.7 microm). A crystallographic complex of GalNAc-isofagomine bound to SpHEX was solved and refined to 1.75 A and revealed that the lack of a strong electrostatic interaction between the "anomeric" center of GalNAc-isofagomine and SpHEX is compensated for by a novel 2.8-A hydrogen bond formed between the equatorial proton of the endocyclic nitrogen of the azasugar ring and the carboxylate of the general acid-base residue Glu-314 of SpHEX. This interaction appears to contribute to the unexpected potency of GalNAc-isofagomine toward SpHEX.

摘要

异夫糖胺类氮杂糖抑制剂是构型保留型β-糖苷酶的强效竞争性抑制剂。这种强效性源于抑制剂“异头”中心的质子化内环氮与酶的催化亲核试剂之间形成的强静电相互作用。尽管大多数构型保留型β-糖苷酶采用涉及羧酸盐残基作为亲核试剂的机制,但褶皱链霉菌β-N-乙酰己糖胺酶(SpHEX)及相关的20家族糖苷酶缺乏这样的催化残基,而是使用底物2-乙酰氨基基团的羰基氧作为亲核试剂来“攻击”异头中心。因此,预计抑制剂与酶之间不会发生强静电相互作用;尽管如此,合成并检测了其抑制SpHEX能力的1-N-氮杂糖(2R,3R,4S,5R)-2-乙酰氨基-3,4-二羟基-5-羟甲基-哌啶盐酸盐(GalNAc-异夫糖胺·HCl)被发现是该酶的强效竞争性抑制剂(Ki = 2.7 μM)。解析并精修了GalNAc-异夫糖胺与SpHEX结合的晶体复合物至1.75 Å,结果显示GalNAc-异夫糖胺的“异头”中心与SpHEX之间缺乏强静电相互作用,这通过氮杂糖环内环氮的赤道质子与SpHEX的一般酸碱残基Glu-314的羧酸盐之间形成的新型2.8 Å氢键得到补偿。这种相互作用似乎有助于GalNAc-异夫糖胺对SpHEX产生意外的强效性。

相似文献

1
Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor.1-N-氮杂糖GalNAc-异夫糖胺作为强效20家族β-N-乙酰己糖胺酶抑制剂的生化及结构评估
J Biol Chem. 2001 Nov 9;276(45):42131-7. doi: 10.1074/jbc.M107154200. Epub 2001 Aug 24.
2
Synthesis and kinetic analysis of the N-acetylhexosaminidase inhibitor XylNAc-isofagomine.
J Org Chem. 2005 Sep 16;70(19):7715-20. doi: 10.1021/jo051117e.
3
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.
Bioorg Med Chem Lett. 2008 May 1;18(9):2944-7. doi: 10.1016/j.bmcl.2008.03.067. Epub 2008 Mar 28.
4
Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors.异叶败酱苷及其衍生物作为强效糖苷酶抑制剂的评估。
Biochemistry. 1996 Feb 27;35(8):2788-95. doi: 10.1021/bi9522514.
5
Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to beta-glucosidases.亚氨基糖糖苷酶抑制剂:异夫糖胺和1-脱氧野尻霉素与β-葡萄糖苷酶结合的结构和热力学剖析
J Am Chem Soc. 2003 Nov 26;125(47):14313-23. doi: 10.1021/ja036833h.
6
Structural and functional characterization of Streptomyces plicatus beta-N-acetylhexosaminidase by comparative molecular modeling and site-directed mutagenesis.通过比较分子建模和定点诱变对褶皱链霉菌β-N-乙酰己糖胺酶进行结构和功能表征
J Biol Chem. 1998 Jul 31;273(31):19618-24. doi: 10.1074/jbc.273.31.19618.
7
A xylobiose-derived isofagomine lactam glycosidase inhibitor binds as its amide tautomer.一种木二糖衍生的异福明内酰胺糖苷酶抑制剂以其酰胺互变异构体的形式结合。
Chem Commun (Camb). 2003 Apr 21(8):944-5. doi: 10.1039/b301829f.
8
Aspartate 313 in the Streptomyces plicatus hexosaminidase plays a critical role in substrate-assisted catalysis by orienting the 2-acetamido group and stabilizing the transition state.褶皱链霉菌己糖胺酶中的天冬氨酸313通过使2-乙酰氨基定向并稳定过渡态,在底物辅助催化中起关键作用。
J Biol Chem. 2002 Oct 18;277(42):40055-65. doi: 10.1074/jbc.M206481200. Epub 2002 Aug 8.
9
Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors.D-和 L-异野尻霉素异构体作为人β-葡糖苷脑苷脂酶抑制剂的对接和 SAR 研究。
Bioorg Med Chem. 2011 Jun 1;19(11):3558-68. doi: 10.1016/j.bmc.2011.04.011. Epub 2011 Apr 13.
10
Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidases.异麦角胺2-乙酰氨基甲基衍生物作为人溶酶体β-己糖胺酶潜在抑制剂的设计与合成
Bioorg Med Chem. 2004 Mar 1;12(5):891-902. doi: 10.1016/j.bmc.2003.12.040.

引用本文的文献

1
Bioinformatic, Enzymatic, and Structural Characterization of Hexosaminidase HEX-2.六己糖胺酶 HEX-2 的生物信息学、酶学和结构特征分析。
Biochemistry. 2024 Aug 6;63(15):1941-1954. doi: 10.1021/acs.biochem.4c00187. Epub 2024 Jul 26.
2
Structural-Functional Analysis Reveals a Specific Domain Organization in Family GH20 Hexosaminidases.结构-功能分析揭示了GH20家族己糖胺酶中的特定结构域组织。
PLoS One. 2015 May 29;10(5):e0128075. doi: 10.1371/journal.pone.0128075. eCollection 2015.
3
Computational study of β-N-acetylhexosaminidase from Talaromyces flavus, a glycosidase with high substrate flexibility.
来自黄曲霉的β-N-乙酰己糖胺酶的计算研究,一种具有高底物灵活性的糖苷酶。
BMC Bioinformatics. 2015 Jan 28;16:28. doi: 10.1186/s12859-015-0465-8.
4
Crystal structures of a glycoside hydrolase family 20 lacto-N-biosidase from Bifidobacterium bifidum.双歧双歧杆菌糖苷水解酶家族 20 乳-N-生物素酶的晶体结构。
J Biol Chem. 2013 Apr 26;288(17):11795-806. doi: 10.1074/jbc.M112.420109. Epub 2013 Mar 11.
5
2-Acetamino-1,2-dideoxynojirimycin-lysine hybrids as hexosaminidase inhibitors.作为己糖胺酶抑制剂的2-乙酰氨基-1,2-二脱氧野尻霉素-赖氨酸杂合物
Tetrahedron Asymmetry. 2009 May 1;20(6-8):832-835. doi: 10.1016/j.tetasy.2009.02.015.
6
Crystallization and diffraction analysis of β-N-acetylhexosaminidase from Aspergillus oryzae.米曲霉β-N-乙酰己糖胺酶的结晶与衍射分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Apr 1;67(Pt 4):498-503. doi: 10.1107/S1744309111004945. Epub 2011 Mar 26.
7
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation.N-乙酰葡糖胺酶抑制剂是诱导细胞O-GlcNAc超糖基化的人O-连接N-乙酰葡糖胺酶的纳摩尔级抑制剂。
Biochem J. 2009 May 13;420(2):221-7. doi: 10.1042/BJ20090110.
8
Structure of the dimeric N-glycosylated form of fungal beta-N-acetylhexosaminidase revealed by computer modeling, vibrational spectroscopy, and biochemical studies.通过计算机建模、振动光谱和生化研究揭示的真菌β-N-乙酰己糖胺酶二聚体N-糖基化形式的结构
BMC Struct Biol. 2007 May 17;7:32. doi: 10.1186/1472-6807-7-32.
9
Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.对真核生物O-连接的N-乙酰葡糖胺水解机制及抑制作用的结构见解
EMBO J. 2006 Apr 5;25(7):1569-78. doi: 10.1038/sj.emboj.7601026. Epub 2006 Mar 16.
10
Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.人β-己糖胺酶B的晶体结构:理解桑德霍夫病和泰-萨克斯病的分子基础
J Mol Biol. 2003 Apr 11;327(5):1093-109. doi: 10.1016/s0022-2836(03)00216-x.